Xenobiotic-induced alterations in thymocyte development

APMIS

Volumn 114, Issue 6, 2006, Pages 399-419

  Drela, Nadzieja ^a  

^a UNIVERSITY OF WARSAW   (Poland)

Author keywords

Arylhydrocarbon receptor; Endocrine disrupters; Estrogen receptor; Particulate matter; Steroid hormone receptors; Thymocyte development; Thymus

Indexed keywords

AROMATIC HYDROCARBON; CHEMICAL AGENT; ENDOCRINE DISRUPTOR; ESTROGEN RECEPTOR; HALOGENATED HYDROCARBON; HEAVY METAL; RECEPTOR; STEROID RECEPTOR; XENOBIOTIC AGENT;

APOPTOSIS; CELL DIFFERENTIATION; CELL MATURATION; CELL MIGRATION; HOMEOSTASIS; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; NONHUMAN; PARTICULATE MATTER; POLLUTANT; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW; T LYMPHOCYTE; THYMOCYTE; THYMUS;

ANIMALS; ENVIRONMENTAL EXPOSURE; HUMANS; T-LYMPHOCYTES; THYMUS GLAND; XENOBIOTICS;

EID: 33745699612     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2006.apm_343.x     Document Type: Review

References (210)

1. Feron VJ, Groten JP, Jonker D, Cassee FR, van Bladeren PJ. Toxicology of chemical mixtures: challenges for today and the future. Toxicology 1995;105:415-27.
2. Simmons JE. Chemical mixtures: challenge for toxicology and risk assessment. Toxicology 1995;105:111-9.
3. Van Loveren H, De Jong WH, Vandebriel RJ, Vos JG, Garssen J. Risk assessment and immunotoxicology. Toxicol Lett 1998;102-103:261-5.
4. Van Loveren H, Slob W, Vandebriel RJ, Hudspith BN, Meredith C, Garssen J. Immunotoxicology: Extrapolation from animal to man - estimation of the risk associated with TBTO exposure. Arch Toxicol 1998;20:285-92.
5. Teuschler LK, Hertzberg RC. Current and future risk assessment guidelines, policy, and methods development for chemical mixtures. Toxicology 1995;105:137-44.
6. Vos JG, Van Loweren H. Experimental studies on immunosuppression: how do they predict for man? Toxicology 1998;129:13-26.
7. Kaiser J. Evidence mounts that tiny particles can kill. Science 2000;289:22-3.
8. Burchiel SW, Lauer FT, McDonald JD, Reed MD. Systemic immunotoxicity in AJ mice following 6-month whole body inhalation exposure to diesel exhaust. Toxicol Appl Pharmacol 2004;196:337-45.
9. Chora̧ży M, Szeliga J, Stróżyk M, Cimander B. Ambient air pollutants in upper Silesia: partial chemical composition and biological activity. Environ Health Persp 1994;102(Suppl 4):61-6.
10. Motykiewicz G, Michalska J, Pendzich J, Malusecka E, Stróżyk M, Kalinowska E, et al. A molecular epidemiology study in women from Upper Silesia, Poland. Toxicol Lett 1998;96-97:195-202.
11. Englert N. Fine particles and human health - a review of epidemiological studies. Toxicol Lett 2004;149:235-42.
12. Soukup JM, Becker S. Human alveolar macrophage responses to air pollution particulates are associated with insoluble components of coarse material, including particulate endotoxin. Toxicol Appl Pharmacol 2001;171:20-6.
13. Becker S, Soukup JW. Exposure to urban air particulates mediated inflammatory response to respiratory viral infection. J Toxicol Environ Health 1999;57:445-57.
14. Heo Y, Parsons PJ, Lawrence DA. Lead differentially modifies cytokine production in vitro and in vivo. Toxicol Appl Pharmacol 1996;138:149-57.
15. Heo Y, Lee WT, Lawrence DA. Differential effects of lead and cAMP on development and activities of Th1- and Th2-lymphocytes. Toxicol Sci 1998;43:172-85.
16. + T cells. Toxicology 2001;169:67-80.
17. Griem P, Wulferink M, Sachs B, Gonzales JB, Gleichmann E. Allergic and autoimmune reactions to xenobiotics: how do they arise? Immunol Today 1998;19:133-41.
18. Bernstein JA, Alexis N, Barnes C, Bernstein IL, Nel A, Peden D, Diaz-Sanchez D, Tarlo SM, Williams PB. Health effects of air pollution. J Allergy Clin Immunol 2004;114:1116-23.
19. Ormstadt H. Suspended particulate matter in indoor air: adjuvants and allergen carriers. Toxicology 2000;152:53-68.
20. Bigazzi PE. Autoimmunity caused by xenobiotics. Toxicology 1997;119:1-21.
21. Hess EY Environmental chemicals and autoimmune disease: cause and effect. Toxicology 2002;181-182:65-70.
22. Pfau JC, Brown JM, Holian A. Silica-exposed mice generate autoantibodies to apoptotic cells. Toxicology 2004;195:167-76.
23. Lawrence DA, McCabe MJ. Immunomodulation by metals. Int Immunopharmacol 2002;2:293-302.
24. Van Zjiverden M, der Fiji A, Bol M, van Pinxteren FA, de Haar C, Penninks AH, et al. Diesel exhaust, carbon black, and silica particles display distinct Th1/Th2 modulating activity. Toxicol Appl Pharmacol 2000;168:131-9.
25. Li N, Sioutas C, Cho A, Schmitz D, Misra C, Sempf J, Wang M, Oberley T, Froines J, Nel A. Ultrafine particulate pollutants induce oxidative stress and mitochondrial damage. Environ Health Perspect 2003;111:455-60.
26. Li N, Hao M, Phalen RF, Hinds WC, Nel AE. Particulate air pollutants and asthma. A paradigm for the role of oxidative stress in PM-induced adverse health effects. Clin Immunol 2003;109:250-65.
27. 2.5-10 (coarse) fractions: evidence of different biological activity. Environ Res 2001;86:254-62.
28. Hetland RB, Cassee FR, Refsnes M, Schwarze PE, Lag M, Boere AJF, Dybing E. Release of inflammatory cytokines, cell toxicity and apoptosis in epithelial lung cells after exposure to ambient air particles of different size fractions. Toxicol In Vitro 2004;18:203-12.
29. Kimber I. Allergy, asthma and the environment: an introduction. Toxicol Lett 1998;102-103:301-6.
30. van Zjiverden M, Granum B. Adjuvant activity of particulate pollutants in different mouse models. Toxicology 2000;152:69-77.
31. Steerenberg PA, Withagen CE, Dormans JA, van Dalen WJ, van Loveren H, Cassee FR. Adjuvant activity of various diesel exhaust and ambient particles in two allergic models. J Toxicol Environ Health 2003;66:1421-39.
32. Granum B, Gaarder PI, Lovik M. IgE adjuvant effect caused by particles - immediate and delayed effects. Toxicology 2001;156:149-59.
33. Lovik M, Hogseth AK, Gaarder PI, Hagemann R, Eide I. Diesel exhaust particles and carbon black have adjuvant activity on the local lymph node response and systemic IgE production to ovalbumin. Toxicology 1997;121:165-78.
34. Whitekus MJ, Li N, Zhang M, Wang M, Horwitz MA, Nelson SK, et al. Thiol antioxidants inhibit the adjuvant effects of aerosolized diesel exhaust particles in a murine model for ovalbumin sensitization. J Immunol 2002;168:2560-76.
35. Heo Y, Saxon A, Hankinson O. Effect of diesel exhaust particles and their components on the allergen-specific IgE and IgG1 response in mice. Toxicology 2001;159:143-58.
36. Granum B, Gaarder PI, Groeng EC, Leikvold RB, Namork E, Lovik M. Fine particles of widely different composition have an adjuvant effect on the production of allergen-specific antibodies. Toxicol Lett 2001;115:171-81.
37. Steerenberg PA, Withagen CET, van Dalen WJ, Dormans JAMA, Cassee FR, Heisterkamp SH, et al. Adjuvant activity of ambient particulate matter of different sites, sizes and seasons in a respiratory allergy mouse model. Toxicol Appl Pharmacol 2004;200:186-200.
38. 10). Free Radical Biol Med 2003;34:1369-82.
39. Gonzales-Flecha B. Oxidant mechanisms in response to ambient air particles. Mol Aspects Med 2004;25:169-82.
40. Shukla A, Timblin C, Berube K, Gordon T, McKinney W, Driscoll K, Vacek P, Mossman BT. Inhaled particulate matter causes expression of nuclear factor (NF)-κB- related genes and oxidant-dependent NF-kappaB activation in vitro. Am J Respir Cell Mol Biol 2000;23:182-7.
41. Schins RPF, Lightbody JH, Borm PJA, Shi T, Donaldson K, Stone V. Inflammatory effects of coarse and fine particulate matter in relation to chemical and biological constituents. Toxicol Appl Pharmacol 2004;195:1-11.
42. Gill J, Malin M, Sutherland J, Gray D, Hollander G, Boyd R. Thymic generation and regeneration. Immunol Rev 2003;195:28-50.
43. Pelayo R, Welner R, Perry SS, Huang J, Baba Y, Yokota T, Kincade PW. Lymphoid progenitors and primary routes to becoming cells of the immune system. Curr Opin Immunol 2005;17:100-7.
44. Germain RN. T-cell development and the CD4-CD8 lineage decision. Nature Rev Immunol 2002;2:309-22.
45. Godfrey DI, Kennedy J, Suda T, Zlotnik A. A developmental pathway involving four phenotypically and functionally distinct subsets of CD3-CD4-CD8-triple-negative adult mouse thymocytes defined by CD44 and CD25 expression. J Immunol 1993;150:4244-52.
46. Amakura Y, Tsutsumi T, Nakamura M, Kitagawa H, Fuijino J, Sasaki K, et al. Preliminary screening of the inhibitory effect of food extracts on activation of the aryl hydrocarbon receptor induced by 2,3,7,8- tetrachlorodibenzo-p-dioxin. Biol Pharm Bull 2002;25:272-4.
47. Denison MS, Nagy SR. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu Rev Pharmacol Toxicol 2003;43:309-34.
48. Guengerich PF, Martin MV, McCormick WA, Nguyen LP, Glover E, Bradfield CA. Aryl hydrocarbon receptor response to indigoids in vitro and in vivo. Arch Biochem Biophys 2004;423:309-16.
49. Seidel SD, Winters GM, Rogers WJ, Ziccardi MH, Li V, Keser B, Denison MS. Activation of the Ah receptor signaling pathway by prostaglandins. J Biochem Mol Toxicol 2001;15:187-96.
50. Li W, Donat S, Dohr O, Unfried K, Abel J. Ah receptor in different tissues of C57BL/6J and DBA/2J mice: use of competitive polymerase chain reaction to measure Ah-receptor mRNA expression. Arch Biochem Biophys 1994;315:279-84.
51. Pollenz RS. The mechanism of AH receptor protein down-regulation (degradation) and its impact on AH receptor-mediated gene regulation. Chem Biol Interact 2002;141:41-61.
52. Hahn ME. The aryl hydrocarbon receptor: a comparative perspective. Comp Biochem Physiol Part C Pharmacol Toxicol Endocrinol 1998;121(1-3):23-53.
53. Pollenz RS, Santostefano MJ, Klett E, Richardson VM, Necela B, Birnbaum LS. Female Sprague-Dawley rats exposed to a single oral dose of 2,3,7,8-tetrachlorodibenzo-p-dioxin exhibit sustained depletion of aryl hydrocarbon receptor protein in liver, spleen, thymus and lung. Toxicol Sci 1998;42:117-28.
54. Staples JE, Murante FG, Fiore NC, Gasiewicz TA, Silverstone AE. Thymic alterations induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin are strictly dependent on aryl hydrocarbon receptor activation in hemopoietic cells. J Immunol 1998;160:3844-54.
55. Laiosa MD, Wyman A, Murante FG, Fiore NC, Staples JE, Gasiewicz TA, Silverstone AE. Cell proliferation arrest within intrathymic lymphocyte progenitor cells causes thymic atrophy mediated by the aryl hydrocarbon receptor. J Immunol 2003;171:4582-91.
56. Nohara K, Ushio H, Tsukumo S, Kobayashi T, Kijima M, Tohyama C, Fujimaki H. Alterations of thymocyte development, thymic emigrants and peripheral T cell population in rats exposed to 2,3,7,8-tertrachlorodibenzo-p-dioxin. Toxicology 2000;145:227-35.
57. Kremer J, Gleichmann E, Esser C. Thymic stroma exposed to arylhydrocarbon receptor-binding xenobiotics fails to support proliferation of early thymocytes but induces differentiation. J Immunol 1994;153:2778-86.
58. + T cells is necessary for full suppression of a cytotoxic T lymphocyte response by TCDD. Toxicol Appl Pharmacol 2002;185:146-52.
59. Lawrence BP, Leid M, Kerkvliet NI. Distribution and behavior of the Ah receptor in murine T lymphocytes. Toxicol Appl Pharmacol 1996;138:275-84.
60. Kerkvliet NI. Recent advances in understanding the mechanisms of TCDD immunotoxicity. Int Immunopharmacol 2002;2:277-91.
61. Hanlon PR, Zheng W, Ko AY, Jefcoate CR. Identification of novel TCDD-regulated genes by microarray analysis. Toxicol Appl Pharmacol 2005;202:215-28.
62. Denison MS, Pandini A, Nagy SR, Baldwin EP, Bonati L. Ligand binding and activation of the Ah receptor. Chem-Biol Interactions 2002;141:3-24.
63. Zhang S, Qin C, Safe SH. Flavonoids as aryl hydrocarbon receptor agonists/antagonists: effects of structure and cell context. Environ Health Persp 2003;111:1877-82.
64. Birnbaum LS. Developmental effects of dioxins. Environ Health Perspect 1995;103(Suppl 7):89-94.
65. Esser C, Steinwachs S, Herder C, Majora M, Lai Z-W. Effects of a single dose of 2,3,7,8-tetrachlorodibenzo-p-dioxin, given at post-puberty, in senescent mice. Toxicol Lett 2005;157:89-98.
66. Safe S. Molecular biology of the Ah receptor and its role in carcinogenesis. Toxicol Lett 2001;120:1-7.
67. Nebert DW, Puga A, Vasiliou V. Role of the Ah receptor and the dioxin-inducible [Ah] gene battery in toxicity, cancer, and signal transduction. Ann NY Acad Sci 1993;685:624-40.
68. Fernandez-Salguero P, Pineau T, Hilbert DM, McPhail T, Lee SS, Kimura S, et al. Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science 1995;268:722-6.
69. Holsapple MP, Karras JG, Ledbetter JA, Schieven GL, Burchiel SW, Davila DR, et al. Molecular mechanisms of toxicant-induced immunosuppression: role of second messengers. Annu Rev Pharmacol Toxicol 1996;36:131-59.
70. Kerkvliet NI. Immunological effects of chlorinated dibenzo-p-dioxins. Environ Health Perspect 1995;103(Suppl 9):47-53.
71. Kremer J, Lai ZW, Esser C. Evidence for the promotion of positive selection of thymocytes by Ah receptor agonist 2,3,7,8-tetrachlorodibenzo-p- dioxin. Eur J Immunol 1995;293:413-27.
72. Lutz CT, Browne G, Petzold CR. Methylcholantrene causes increased thymocyte apoptosis. Toxicology 1998;128:151-67.
73. Lai ZW, Fiore NC, Gasiewicz TA, Silverstone AE. 2,3,7,8- Tetrachlorodibenzo-p-dioxin and diethylstilbestrol affect thymocytes at different stages of development in fetal thymus organ culture. Toxicol Appl Pharmacol 1998;149:167-77.
74. + cells in major histocompatibility complex class I-deficient mice upon activation of the aryl hydrocarbon receptor by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Immunology 2000;100:185-93.
75. Kamath AB, Camacho I, Nagarkatti PS, Nagarkatti M. Role of Fas-Fas ligand interactions in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced immunotoxicity: increased resistance of thymocytes from Fas-deficient (lpr) and Fas-ligand-defective (gld) mice to TCDD-induced toxicity. Toxicol Appl Pharmacol 1999;160:141-55.
76. Lai ZW, Fiore NC, Hahn PJ, Gasiewicz TA, Silverstone AE. Differential effects of diethylstibestrol and 2,3,7,8-tetrachlorodibenzo-p-dioxin on thymocyte differentiation, proliferation, and apoptosis in bcl-2 transgenic mouse fetal thymus organ culture. Toxicol Appl Pharmacol 2000;168:15-24.
77. Camacho IA, Nagarkatti M, Nagarkatti PS. Evidence for induction of apoptosis in T cells from murine fetal thymus following perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicol Sci 2004;78:96-106.
78. Kip1 induction and inhibition of proliferation by the intracellular Ah receptor in developing thymus and hepatoma cells. Genes Dev 1999;13:1742-53.
79. Thurmond TS, Staples JE, Silverstone AE, Gasiewicz TA. The aryl hydrocarbon receptor has a role in the in vivo maturation of murine bone marrow B lymphocytes and their response to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Appl Pharmacol 2000;165:227-36.
80. Whitlock JP Jr. Induction of cytochrome P4501A1. Annu Rev Pharmacol Toxicol 1999;39:103-25.
81. Mimura J, Fujii-Kuriyama Y. Functional role of AhR in the expression of toxic effects by TCDD. Bioch Biophys Acta 2003;1619:263-8.
82. Tian Y, Rabson AB, Gallo MA. Ah receptor and NF-κB interactions: mechanisms and physiological implications. Chem Biol Interact 2002;141:97-115.
83. Nebert DW, Roe AL, Dieter MZ, Solis WA, Yang Y, Dalton TP. Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis. Biochem Pharmacol 2000;59:65-85.
84. Puga A, Xia Y Elferink C. Role of the aryl hydrocarbon receptor in cell cycle regulation. Chem Biol Interact 2002;141:117-30.
85. Jeon MS, Esser C. Induction of IL-2 by 2,3,7,8-tetrachlorodibenzo-p- dioxin in fetal thymocytes and mature T-cells of the mouse. Organohalogen Comp 1997;34:100-3.
86. Lai ZW, Pineau T, Gleichmann E, Esser C. Cytokine gene expression during ontogeny in murine thymus upon activation of the Ah receptor by 2,3,7,8-tetrachlorodibenzo-p-dioxin. MoI Pharmacol 1997;52:30-7.
87. Puga A, Tomlinson CR, Xia Y. Ah receptor signals cross-talk with multiple developmental pathways. Biochem Pharmacol 2005;69:199-207.
88. Hoffer A, Chang CY, Puga A. Dioxin induces transcription of fos and jun genes by Ah receptor-dependent and independent pathway. Toxicol Appl Pharmacol 1996;141:238-47.
89. Zeytun A, McKallip RJ, Fisher M, Camacho I, Nagarkatti M, Nagarkatti PS. Analysis of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced gene expression profile in vivo using pathway-specific cDNA arrays. Toxicology 2002;178:241-60.
90. Jain S, Maltepe E, Lu MM, Simon C, Bradfield CA. Expression of ARNT ARNT2, HIF1 alpha, HIF2 alpha and Ah receptor mRNAs in the developing mouse. Mech Dev 1998;73:117-23.
91. Hundeiker C, Pineau T, Cassar G, Betensky RA, Gleichmann E, Esser C. Thymocyte development in Ah-receptor-deficient mice is refractory to TCDD-inducible changes. Int J Immunopharmacol 1999;21:841-59.
92. Nohara K, Pan X, Tsukumo S, Hida A, Ito T, Nagai H, et al. Constituvely active aryl hydrocarbon receptor expressed specifically in T-lineage cells causes thymus involution and suppresses the immunization-induced increase in splenocytes. J Immunol 2005;174:2770-7.
93. Staples JE. Fiore NC, Frazier DE Jr, Gasiewicz TA, Silverstone AE. Overexpression of the antiapoptotic oncogene, bcl-2, in the thymus does not prevent thymic atrophy induced by estradiol or 2,3,7,8-tertrachlorodibenzo-p- dioxin. Toxicol Appl Pharmacol 1998;151:200-10.
94. Fernandez-Salguero PM, Hilbert DM, Rudikoff S, Ward JM, Gonzales FJ. Aryl-hydro-carbon receptor-deficient mice are resistant to 2,3,7,8- tetrachlorodibenzo-p-dioxin-induced toxicity. Toxicol Appl Pharmacol 1996;140:173-9.
95. Tomita S, Jiang HB, Ueno T, Takagi S, Tohi K, Maekawa S, Miyatake A, Furukawa A, Gonzales FJ, Takeda J, Ichikawa Y, Takahama Y. T-cell specific disruption of arylhydrocarbon receptor nuclear translocator (Arnt) gene causes resistance to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced thymic involution. J Immunol 2003;171:4113-20.
96. Fisher MT, Nagarkatti M, Nagarkatti PS. 2,3,7,8-tetrachlorodibenzo-p- dioxin enhances negative selection of T cells in the thymus but allows autoreactive T cells to escape deletion and migrate to the periphery. Mol Pharmacol 2005;67:327-35.
97. Esser C, Temchura V, Majora M, Hundeiker C, Schwarzler C, Gunthert U. Signaling via the AHR leads to enhanced usage of CD44v10 by murine fetal thymic emigrants: possible role for CD44 in emigration. Int Immunopharmacol 2004;4:805-18.
98. Svensson C, Silverstone AE, Lai ZW, Lundberg K. Dioxin-induced adseverin expression in the mouse thymus is strictly regulated and dependent on the aryl hydrocarbon receptor. Biochem Biophys Res Commun 2002;291:1194-200.
99. Jeon MS, Esser C. The murine IL-2 promoter contains distal regulatory elements responsive to the Ah receptor, a member of the evolutionary conserved bHLH-PAS transcription factor family. J Immunol 2000;165:6975-83.
100. Schwarzler C, Oliferenko S, Gunthert U. Variant isoforms of CD44 are required in early thymocyte development. Eur J Immunol 2001;31:2997-3005.
101. Besedovsky HO, Del Rey A. Immune-neuro-endocrine interactions: facts and hypothesis. Endoer Rev 1996;17:64-102.
102. Savino W, Dardenne M. Neuroendocrine control of thymus physiology. Endocr Rev 2000;21:412-43.
103. Webster JI, Tonelli L, Sternberg EM. Neuroendocrine regulation of immunity. Annu Rev Immunol 2002;20:125-63.
104. Colton CA, Brown CM, Vitek MP. Sex steroids, APOE genotype and the innate immune system. Neurobiol Aging 2005;26:363-72.
105. Ashwell JD, Lu FWM, Vacchio MS. Glucocorticoids in T cell development and function. Annu Rev Immunol 2000;18:309-45.
106. Lang TL. Estrogen as an immunomodulator. Clin Immunol 2004;113:224-30.
107. Benten WPM, Becker A, Schmitt-Wrede HP, Wunderlich F. Developmental regulation of intracellular and surface androgen receptors in T cells. Steroids 2002;67:925-31.
108. Falkenstein E, Tillmann HC, Christ M, Feuring M, Wehling M. Multiple actions of steroid hormones - a focus on rapid, nongenomic effects. Pharmacol Rev 2000;52:513-55.
109. Verthelyi D. Sex hormones as immunomodulators in health and disease. Int Immunopharmacol 2001;1:983-93.
110. Olsen NJ, Kovacs WJ. Gonadal steroids and immunity. Endocr Rev 1996;17:369-84.
111. Kovacs EJ, Messingham KAN, Gregory MS. Estrogen regulation of immune responses after injury. Mol Cell Endocrinol 2002;193:129-35.
112. Kawashima I, Sakabe K, Seiki K, Fuji-Hanamoto H, Akatsuka A, Tsukamoto H. Localization of sex steroid receptor cells, with special reference to thymulin (FTS)-producing cells in female rat thymus. Thymus 1991;18:79-93.
113. Sakabe K, Okuma M, Karaki S, Matsuura S, Yoshida T, Aikawa H, Izumi S, Kayama F. Inhibitory effect of natural and environmental estrogens on thymic hormone production in thymus epithelial cell culture. Int J Immunopharmacol 1999;21:861-6.
114. Berki T, Palinkas L, Boldizsar F, Nemeth P. Glucocorticoid (GC) sensitivity and GC receptor expression differ in thymocyte subpopulations. Int Immunol 2002;14:463-9.
115. Miller AH, Spencer RL, Pearce BD, Pisell TL, Azrieli Y, Tanapat P, Moday H, Rhee R, McEven BC. Glucocorticoid receptors are differently expressed in T cells and tissues of the immune system. Cell Immunol 1998;186:45-54.
116. Uotinen N, Puustinen R, Pasanen S, Manninen T, Kivineva M, Syvala H, Tuohimaa P, Ylikomi T. Distribution of progesterone receptor in female mouse tissues. Gen Comp Endocrinol 1999;115:429-41.
117. Benten WPM, Stephan C, Wunderlich F. B cells express intracellular but not surface receptors for testosterone and estradiol. Steroids 2002;67:647-54.
118. Gutendorf B, Westendorf J. Comparison of an array of in vitro assays for the assessment of the estrogenic potential of natural and synthetic estrogens, phytoestrogens and xenoestrogens. Toxicology 2001;166:79-89.
119. Erlandsson MC, Ohlsson C, Gustafsson JA, Carlsten H. Role of estrogen receptors alpha and beta in immune organ development and in oestrogen-mediated effects on thymus. Immunology 2001;103:17-25.
120. Li CL, Toda K, Saibara T, Zhang T, Ono M, Iwasaki S, et al. Estrogen deficiency results in enhanced expression of Smoothened of the Hedgehog signaling in the thymus and affects thymocyte development. Int Immunopharmacol 2002;2:823-33.
121. Lombardi G, Zarrilli S, Colao A, Paesano L, Di Somma C, Rossi F, De Rosa M. Estrogens and health in males. Mol Cell Endocrinol 2001;178:51-5.
122. Yellayi S, Teuscher C, Woods JA, Welsh TH Jr, Tung KS, Nakai M, et al. Normal development of thymus in male and female mice requires estrogen/estrogen receptor-alpha signaling pathway. Endocrine 2000;12:207-13.
123. Selvaraj V, Bunick D, Finnigan-Bunick C, Johnson RW, Wang H, Liu L, Cooke PS. Gene expression profiling of 17β-estradiol and genistein effects on mouse thymus. Toxicol Sci 2005;87:97-112.
124. Medina KL, Strasser A, Kincade PW. Estrogen influences the differentiation, proliferation and survival of early B-lineage precursors. Immunobiology 2000;95:2059-67.
125. Torres-Roca JF, Tung JW, Greenwald DR, Brown JM, Herzenberg LA, Herzenberg LA, Katsikis PD. An early oxygen-dependent step is required for dexamethasone-induced apoptosis of immature mouse thymocytes. J Immunol 2000;165:4822-30.
126. Yao G, Hou Y. Thymic atrophy via estrogen-induced apoptosis is related to Fas/FasL pathway. Int Immunopharmacol 2004;4:213-21.
127. Okasha SA, Ryu S, Do Y, McKallip RJ, Nagarkatti M, Nagarkatti P.S. Evidence for estradiol-induced apoptosis and dysregulated T cell maturation in the thymus. Toxicology 2001;163:49-62.
128. Dulos GJ, Bagchus WM. Androgens indirectly accelerate thymocyte apoptosis. Int Immunopharmacol 2001;1:321-8.
129. Olsen NJ, Viselli SM, Fan J, Kovacs WJ. Androgens accelerate thymocyte apoptosis. Endocrinology 1998;139:748-52.
130. Olsen NJ, Kovacs WJ. Effects of androgens on T and B lymphocyte development. Immunol Res 2001;23:281-8.
131. Moynihan JA, Callahan TA, Kelley SP, Campbell LM. Adrenal hormone modulation of thype 1 and type 2 cytokine production by spleen cells: dexamethasone and dehydroepiandrosterone suppress interleukin-2, interleukin-4 and interferon-γ production in vitro. Cell Immunol 1998;184:58-64.
132. Kalaitzidis D, Gilmore TD. Transcription factor cross talk: the estrogen receptors and NF-κB. Trends Immunol 2005;16:46-52.
133. Leposavic G, Obradovic S, Kosec D, Pejcic-Karapetrovic B, Vidic-Dankovic B. In vivo modulation of the distribution of thymocyte subsets by female sex steroid hormones. Int Immunopharmacol 2001;1:1-12.
134. Staples JE, Gasiewicz TA, Fiore NC, Lubahn DB, Korach KS, Silverstone AE. Estrogen receptor is necessary in thymic development and estradiol-induced thymic alterations. J Immunol 1999;163:4168-74.
135. Igarashi H, Kouro T, Yokota T, Comp PC, Kincade PW. Age and stage dependency of estrogen receptor expression by lymphocyte precursors. Proc Natl Acad Sci USA 2001;98:15131-36.
136. He W, Sakabe K, Sakai N, Seiki K. Sex steroid modulation of thymic hormones production in thymus epithelial cell culture. Pathophysiology 1996;3:169-74.
137. Safadi FF, Dissanayake IR, Goodman GG, Jago RA, Baker AE, Bowman AR, Sass DA, Popoff SN, Epstein S. Influence of estrogen deficiency and replacement on T-cell populations in rat lymphoid tissues and organs. Endocrine 2000;12:81-8.
138. Tibbetts TA, DeMayo F, Rich S, Conneely OM, O'Malley BW. Progesterone receptors in the thymus are required for thymic involution during pregnancy and for normal fertility. Proc Natl Acad Sci USA 1999;96:12021-6.
139. Jondal M, Pazirandeh A, Okret S. Different roles for glucocorticoids in thymocyte homeostasis? Trends Immunol 2004;25:595-600.
140. Vacchio MS, Ashwell JD. Glucocorticoids and thymocyte development. Semin Immunol 2000;12:475-86.
141. Marchetti MC, Di Marco B, Santini MC, Bartoli A, Delfino DV, Riccardi C. Dexamethasone-induced thymocyte apoptosis requires glucocorticoids receptor nuclear translocation but not mitochondrial membrane transition. Toxicol Lett 2003;139:175-80.
142. + TCR(low) thymocytes express low levels of glucocorticoids receptors while being sensitive to glucocorticoid-induced apoptosis. Eur J Immunol 2001;31:2293-301.
143. Gerpe-Domininguez L, Rey-Mendez M. Modulation of stress-induced lymphoid tissue involution by age, sex and strain: role of bone marrow. Mech Ageing Dev 1998;104:195-205.
144. McMurray RC, Wilson JG, Bigler L, Xiang L, Lagoo A. Progesterone inhibits glucocorticoid-induced murine thymocyte apoptosis. Int J Immunopharmacol 2000;22:955-65.
145. + immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 2002;16:311-23.
146. Karagiannidis C, Akdis M, Holopainen P, Wooley NJ, Hense G, Ruckert B, Mantel PY, Menz G, Akdis CA, Blaser K, Schmidt-Weber CB. Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. J Allergy Clin Immunol 2004;114:1425-33.
147. Thompson ED. Mechanisms of T-cell apoptosis induced by glucocorticoids. Trends Endocrinol Met 1999;10:353-8.
148. Gould KA, Shull JD, Gorski J. DES action in the thymus: inhibition of cell proliferation and genetic variation. Mol Cell Endocrinol 2000;170:31-9.
149. Pruett SB, Padgett EL. Thymus-derived glucocorticoids are insufficient for normal thymus homeostasis in the adult mouse. BMC Immunol 2004;5:1-14.
150. Godfrey DI, Purton JF, Boyd RL, Cole TJ. Stress-free T-cell development: glucocorticoids are not obligatory. Immunol Today 2000;21:606-11.
151. Ashwell JD, King LB, Vacchio MS. Cross-talk between the T cell antigen receptor and the glucocorticoids receptor regulates thymocyte development. Stem Cells 1996;14:490-500.
152. Wira CR, Fahey JV, Abrahams VM, Rossoll RM. Influence of stage of the reproductive cycle and estradiol on thymus cell antigen presentation. J Steroid Biochem Mol Biol 2003;84:79-87.
153. Wang W, Wyrzykowska J, Johnson T, Sen R, Sen J. A NF-κB/c-myc- dependent survival pathway is targeted by corticosteroids in immature thymocytes. J Immunol 1999;162:314-22.
154. Mendes JJA. The endocrine disrupters: a major medical challenge. Food Chem Toxicol 2002;40:781-8.
155. Ansar Ahmed S. The immune system as a potential target for environmental estrogens (endocrine disruptors): a new emerging field. Toxicology 2000;150:191-206.
156. Neubert D. Vulnerability of the endocrine system to xenobiotic influence. Reg Toxicol Pharmacol 1997;26:9-29.
157. Wester PW, van der Ven LTM, Vos JG. Comparative toxicological pathology in mammals and fish: some examples with endocrine disrupters. Toxicology 2004;205:27-32.
158. Cha SW, Lee HJ, Cho MH, Lee MH, Koh WS, Han SS, et al. Role of corticosterone in ethyl carbamate-induced immunosuppression in female BALB/c mice. Toxicol Lett 2001;119:173-81.
159. Utsuyama M, Kanno J, Inoue T, Hirokawa, K. Age/sex dependent and non-monotonous dose-response effect of diethylstilbestrol on the immune functions in mice. Toxicol Lett 2002;135:145-53.
160. Calemine J, Zalenka J, Karpuzoglu-Sahin E, Ward DL, Lengi A, Ahmed SA. The immune system in geriatric mice is modulated by estrogenic endocrine disruptors (diethylstilbestrol, α-zearalanol, and genistein): effects on interferon-γ. Toxicology 2003;194:115-28.
161. Calemine J, Gogal R, Lengi A, Sponenberg P, Ahmed S. Immunomodulation by ethylstilbestrol is dose and gender related: effects on thymocyte apoptosis and mitogen-induced proliferation. Toxicology 2002;178:101-18.
162. Fenaux JB, Gogal Jr RM, Ansar Ahmed S. Diethylstilbestrol exposure during fetal development affects thymus: studies in fourteen-month-old mice. J Reprod Immunol 2004;64:75-90.
163. Holladay SD, Blaylock BL, Comment CE, Heindel JJ, Fox WM, Korach KS, Luster MI. Selective prothymocyte targeting by prenatal diethylstilbestrol exposure. Cell Immunol 1993;152:131-42.
164. Smith BJ, Holladay SD. Immune alterations in geriatric mice dosed subacutely with diethylstilbestrol (DES). J Appl Toxicol 1997;17:265-71.
165. Forsberg JG. Neonatal estrogen treatment and its consequences for thymus development, serum level of autoantibodies to cardiolipin, and the delayed-type hypersensitivity response. J Toxicol Environ Health A 2000;60:185-213.
166. Guo TL, Zhang XL, Bartolucci E, McCa, JA, White KL Jr, You L. Genistein and methoxychlor modulate the activity of natural killer cells and the expression of phenotypic markers by thymocytes and splenocytes in F0 and F1 generations of Sprague-Dawley rats. Toxicology 2002;172:205-15.
167. Yellayi S, Naaz A, Szewczykowski MA, Sato T, Woods JA, Chang J, et al. The phytoestrogen genistein induces thymic and immune changes: a human health concern? Proc Nat Acad Sci USA 2002;99:7616-21.
168. Klein SL, Wisniewski AB, Marson AL, Glass GE, Gearhart JP. Early exposure to genistein exerts lon-lasting effects on the endocrine and immune system in rats. Mol Med 2002;8:742-9.
169. Csaba G, Inczefi-Gonda A. Effect of a single treatment (imprinting) with genistein or combined treatment with genistein + benzpyrene on the binding capacity of glucocorticoid and estrogen receptors of adult rats. Hum Exp Toxicol 2002;21:231-4.
170. Calabrese EJ. Hormetic dose-response relationships in immunology: occurrence, quantitative features of the dose response, mechanistic foundations, and clinical implications. Crit Rev Toxicol 2005;35:89-295.
171. Watson CS, Gametchu B. Membrane estrogen and glucocorticoids receptors-implications for hormonal control of immune function and autoimmunity. Int Immunopharmacol 2001;1:1049-63.
172. Veronesi B, Oortgiesen M. Neurogenic inflammation and particulate matter (PM) air pollutants. Neurotoxicology 2001;22:795-810.
173. Li M, Xia T, Jiang CS, Li LJ, Fu JL, Zhou ZC. Cadmium directly induced the opening of membrane permeability pore of mitochondria which possibly involved in cadmium-triggered apoptosis. Toxicology 2003;194:19-33.
174. Bagchi D, Bagchi M, Stohs SJ. Chromium (VI)-induced oxidative stress, apoptotic cell death and modulation of p53 tumor suppressor gene. Mol Cell Biochem 2001;222:149-58.
175. Chen F, Vallyathan V, Castranova V, Shi X. Cell apoptosis induced by carcinogenic metals. Mol Cell Biochem 2001;222:183-8.
176. Pulido MD, Parrish AR. Metal-induced apoptosis: mechanisms. Mutat Res 2003;533:227-41.
177. Chukhlovin AB, Tokalov SV, Yagunov AS, Westendorf J, Reincke H, Karbe L. In vitro suppression of thymocyte apoptosis by metal-rich complex environmental mixtures: potential role of zinc and cadmium excess. Sci Total Environ 2001;281:153-63.
178. + T cells. Toxicology 2001;169:53-65.
179. Krocova Z, Macela A, Kroca M, Hernychova L. The immunomodulatory effect(s) of lead and cadmium on the cells of immune system in vitro. Toxicol In Vitro 2000;14:33-40.
180. Lynes MA, Fontenot AP, Lawrence DA, Rosenspire AJ, Pollard KM. Gene expression influences on metal immunomodulation. Toxicol Appl Pharmacol 2006;210:9-16.
181. Dong S, Shen HM, Ong CN. Cadmium-induced apoptosis and phenotypic changes in mouse thymocytes. Mol Cell Biochem 2001;222:11-20.
182. Fujimaki H, Ishido M, Nohara K. Induction of apoptosis in mouse thymocytes by cadmium. Toxicol Lett 2000;115:99-105.
183. Kim SH, Johnson VJ, Sharma RP. Oral exposure to inorganic mercury alters T lymphocyte phenotype and cytokine expression in BALB/c mice. Arch Toxicol 2003;77:613-20.
184. Valentino M, Santarelli M, Pieragostini E, Soleo L, Mocchegiani E. In vitro inhibition of thymulin production in mercury-exposed thymus of young mice. Sci Total Environ 2001;270:109-12.
185. Kuvibidila SR, Porretta C. Iron deficiency and in vitro iron chelation reduce the expression of cluster differentiation molecule CD28 but not CD3 receptors on murine thymocytes and spleen cells. Br J Nutr 2003;90:179-89.
186. Hosea HJ, Rector ES, Taylor CG. Dietary repletion can replenish reduced T cell subset numbers and lymphoid organ weight in zinc-deficient and energy-restricted rats. Br J Nutr 2004;91:741-7.
187. +) T lymphocytes in spleen and blood. J Nutr 2003;133:4239-42.
188. Szuster-Ciesielska A, Stachura A, Słotwińska M, Kamińska T, Śnieżko R, Paduch R, et al. The inhibitory effect of zinc on cadmium-induced cell apoptosis and reactive oxygen species (ROS) production in cell cultures. Toxicology 2000;145:159-71.
189. Moore JB, Blanchard RK, Cousins RJ. Dietary zinc modulates gene expression in murine thymus: results from a comprehensive differential display screening. Proc Nat Acad Sci USA 2003;100:3883-8.
190. Kondoh M, Imada N, Kamada K, Tsukahara R, Higashimoto M, Takiguchi M, et al. Property of metallothionein as a Zn pool differs depending on the induced condition of metallothionein. Toxicol Lett 2003;142:11-8.
191. Kondoh M, Tsukada M, Kuronaga M, Higashimoto M, Takiguchi M, Himeno S, et al. Induction of hepatic metallothionein synthesis by endoplasmic reticulum stress in mice. Toxicol Lett 2004;148:133-9.
192. Mocchegiani E, Verbanac D, Santarelli L, Tibaldi A, Muzzioli M, Radosevic-Stasic B, Milin C. Zinc and metallothioneins on cellular immune effectiveness during liver regeneration in young and old mice. Life Sci 1997;61:1125-45.
193. Jacob ST, Ghoshal K, Sheridan JF. Induction of metallothionein by stress and its molecular mechanisms. Gene Expr 1999;7:301-10.
194. Macedo MF, De Sousa M, Ned RM, Mascarenhas C, Andrews NC, Correia-Neves M. Transferrin is required for early T-cell differentiation. Immunology 2004;112:543-9.
195. Bowlus CL. The role of iron in T cell development and autoimmunity. Autoimm Rev 2003;2:73-8.
196. Kozłowska E, Krzystyniak K, Drela N, Grabarczyk P, Izdebska-Szymona K. Thymus-directed immunotoxicity of airborne dust particles from Upper Silesia (Poland) under acute extrapulmonary studies in mice. J Toxicol Environ Health 1996;49:563-79.
197. Drela N, Żeśko I. Gender-related early immune changes in mice exposed to airborne suspended matter. Immunopharmacol Immunotoxicol 2003;25:101-21.
198. Watanabe N, Kurita M. The masculinization of the fetus during pregnancy due to inhalation of diesel exhaust. Environ Health Persp 2001;109:111-9.
199. Sacedon R, Vicente A, Varas A, Jimenez E, Munoz JJ, Zapata AG. Early maturation of T-cell progenitors in the absence of glucocorticoids. Blood 1999;94:2819-26.
200. Parel Y, Chizzolini C. CD4+CD8+ double positive (DP) T cells in health and disease. Autoimmun Rev 2004;3:215-20.
201. Drela N, Bień J, Kozłowska E. T-cell homeostasis in mice exposed to airborne xenobiotics. Immunology 2005;114:476-83.
202. Drela N, Radzikowska A. lymphocyte proliferation and activation marker expression in mice exposed to airborne suspended matter. Acta Biologica Cracoviensia Serie Zoologia 2002;44:85-98.
203. Fry TJ, Connick E, Falloon J, Lederman MM, Liewerh DJ, Spritzler J, et al. A potential role for IL-7 in T cell homeostasis. Blood 2001;7:2983-90.
204. Drela N, Zesko I, Biernat P. Cytokines production is altered in mice exposed to airborne suspended matter. Immunopharmacol Immunotoxicol 2002;24:497-525.
205. Aronica MA, Goenke S, Boothby M. IL-4-dependent induction of BCL-2 and BLL-X(L) in activated T lymphocytes through a STAT6 and PI3-kinase independent pathway. Cytokine 2000;12:578-87.
206. Bassiri H, Carding SR. A requirement for IL-2/IL-2 receptor signaling in intrathymic negative selection. J Immunol 2001;166:5945-54.
207. Whalen BJ, Marounek J, Mordes JP, Rossini AA, Greiner DL. Type 1 cytokines polarize thymocytes during T cell development in adult thymus organ cultures. J Autoimmun 2003;20:27-42.
208. Sancho D, Gomez M, Sanchez-Madrid F. CD69 is an immunoregulatory molecule induced following activation. Trends Immunol 2005;26:136-40.
209. Feng C, Woodside KJ, Vance BA, El-Khoury D, Canelles M, Lee J, et al. A potential role for CD69 in thymocyte emigration. Int Immunol 2001;4:535-44.
210. + T cell subsets: abnormal expression in rheumatoid arthritis. Clin Immunol 2001;99:253-65.